ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS

Project: Research project

Description

DESCRIPTION (provided by applicant): The University of Miami?s Division of
Adolescent Medicine seeks membership in the proposed Adolescent Medicine
Trials Network (ATN)for HIV/AIDS Interventions. With worldwide data
demonstrating increasing numbers of young people with HIV infection, it will
be important to continue efforts at discerning unique characteristics of the
infection in young people, including their reactions to it; searching for
improved treatments, including factors correlated with better adherence
patterns; studying behaviors that are identified to put young people at risk
for HIV infection, and then addressing how to change them; developing other
effective prevention strategies including vaccination; and, ultimately,
discovering the cure for this devastating process.
A research agenda would be designed subsequent to the establishment of the
ATN. This entity likely would operate in cooperation and collaboration with
other NIH related efforts regarding lily infection.
StatusFinished
Effective start/end date4/16/012/28/17

Funding

  • National Institutes of Health: $741,657.00
  • National Institutes of Health: $1,087,542.00
  • National Institutes of Health: $561,483.00
  • National Institutes of Health: $272,082.00
  • National Institutes of Health: $644,822.00
  • National Institutes of Health: $560,151.00
  • National Institutes of Health: $677,248.00
  • National Institutes of Health: $664,167.00
  • National Institutes of Health: $580,069.00
  • National Institutes of Health: $633,893.00
  • National Institutes of Health: $641,762.00
  • National Institutes of Health: $668,218.00
  • National Institutes of Health: $603,567.00
  • National Institutes of Health: $649,017.00
  • National Institutes of Health: $502,388.00

Fingerprint

Adolescent Medicine
Acquired Immunodeficiency Syndrome
HIV
HIV Infections
Research
Lilium
Medicine
Vaccination
Young Adult
Therapeutic Community
Healthy People Programs
Therapeutics
Age Groups
Infection
Tertiary Prevention
AIDS Vaccines
Health Promotion
Health
Primary Prevention
Secondary Prevention